View a list of clinical trials and publications involving our faculty.
For more information about our cardiovascular clinical research, visit the Lindner Research Center.
• Women’s Heart Center Long-term Follow-up Registry (Role: PI)
Funding: Investigator-initiated
Status: Enrolling
Description: Prospective registry of all patients managed as part of the Women’s Heart Center’s specialized programs.
• CRT Biorepository (Role: PI)
Funding: Investigator-initiated
Status: Enrolling
Description: Prospective biorepository of all patients undergoing invasive coronary function test for coronary microvascular and vasomotor dysfunction.
• SERRA-I (Role: Site PI)
Funding: Industry
Status: Enrolling
Description: A global, prospective, multi-center, single-arm, early feasibility, first-in-human study of a self-expanding coronary sinus reducer for treatment of symptomatic coronary microvascular dysfunction (CMD) in INOCA (SERRA-I study)
• Block-VSA (Role: PI)
Funding: Industry (ExploraMed)
Status: Enrolling
Description: A prospective, single-arm feasibility clinical study of ischemic ECG changes in INOCA patients with microvascular or epicardial spasm undergoing stellate ganglion block.
• EASi-PROTKT CVRR (Role: Site PI)
Funding: Industry (Boehringer Ingelheim)
Status: Enrolling
Description: A Phase III Double-blind, Randomized, Parallel-group Superiority Trial to Evaluate Efficacy and Safety of the Combined Use of Oral Vicadrostat (BI 690517) and Empagliflozin Compared with Placebo and Empagliflozin in Participants With Type 2 Diabetes, Hypertension and Established Cardiovascular Disease.
• Discover Ischemia with Non-Obstructive Coronary Arteries (INOCA) (Role: Site Co-I)
Funding: Yale Cardiovascular Research Group
Status: Enrolling
Description: A prospective, multicenter, registry of stable patients with ischemia and no obstructive coronary artery disease (INOCA) evaluated by coronary angiography, intravascular imaging, and physiologic measurements.
• Resonance Registry (Role: Site Co-I)
Funding: Industry (Kiniksa Pharma)
Status: Enrolling
Description: Registry to understand the natural history of recurrent pericarditis (RP), as well as document RP-related clinical, health-related quality of life (HRQoL), and economic burden and will assist the medical community to refine or develop data-driven recommendations for clinical management of RP patients to optimize clinical outcomes.
• KPL-387-C212 (Role: Site Co-I)
Funding: Industry (Kiniksa Pharma)
Status: Enrolling
Description: Phase 2 Posology Study With Long-Term Extension in Participants with Well-Controlled Recurrent Pericarditis to Evaluate the Efficacy and Safety of Transition Regimens to KPL-387 Monotherapy From Standard Therapies.
• Polaris HFpEF (Role: Site Co-I)
Funding: Industry (Novo Nordisk)
Status: Enrolling
Description: Interventional, randomized, double-blind, placebo-controlled, two-armed, parallel-group, multicenter, multinational clinical study to look at efficacy and safety of NNC0487-0111 compared to placebo on morbidity and mortality in people with heart failure with preserved or mildly reduced ejection fraction and obesity.
• Empower CAD (Role: Site PI)
Funding: Industry Sponsor, Shockwave Medical, Inc.
Status: Enrolling
Description: To generate real-world clinical evidence associated with coronary intravascular lithotripsy in a population of female and underserved minority patients with calcified coronary artery disease.
• COSIRA II (Role: Site Co-I)
Funding: Industry Sponsor, Neovasc
Status: Enrolling
Description: To demonstrate the safety and effectiveness of the coronary sinus reducer system for treatment of patients with refractory angina pectoris.
• Hypertensive Disorder of Pregnancy (Role: PI)
Funding: National Institutes of Health, Heart Lung, and Blood Institute
Status: Data Analysis
Description: Determine the extent to which measures of coronary microvascular dysfunction and biochemical stress are related to abnormalities in cardiac structure and function that persist in women with prior preeclampsia.
• WARRIOR-Women’s Ischemia Trial to Reduce Events in Non-Obstructive Coronary Arteries (Role: Site PI)
Funding: United States of America, Department of Defense
Status: In Follow-Up
Description: The purpose of this study is to determine whether aggressive medication treatment to modify risk factors in women with non-obstructive coronary artery disease but with cardiac symptoms (i.e., chest pain) will reduce major adverse cardiovascular events as compared to usual care.
• HARP-Heart Attack Research Program (Role: Site PI)
Funding: Sponsor, Sarah Ross Soter Center of The AHA Go Red for Women Research Network at NYU
Status: In Follow-up
Description: Diagnostic observational study in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) to determine the prevalence and composition of disrupted plaque and location of myocardial abnormalities.
• Liberate-OLE 003-007 (Role: Site Co-I)
Funding: Industry Sponsor, LIB Therapeutics, LLC.
Status: In Follow-Up
Description: To assess the long-term safety, tolerability, and efficacy after 48 and 72 weeks with monthly dosing of LIB003 300 mg administered subcutaneously. LIB003 is an anti-PCSK9 small binding protein consisting of an Adnectin-fused human serum albumin in order to prevent its rapid renal clearance and enhance its half-life in circulation. Randomization: none. This is an open label extension of Liberate 003-005, 006 or 011.
• ARIES HM3 (Role: Site Co-I)
Funding: Industry Sponsor, Abbott Cardiovascular Systems, Inc.
Status: In Follow-Up
Description: To study the safety and efficacy of an anti-platelet-free antithrombotic regimen in patients with advanced heart failure treated with the Heart Mate 3 (HM3 LVAS). The HM3 is FDA approved. Vitamin K antagonist therapy will be per standard of care with a target INR of 2.0-3.0. Randomization is 1:1 to 100mg aspirin versus placebo.
• ELITE (Role: Site Co-I)
Funding: Industry Sponsor, Medtronic
Status: In Follow-Up
Description: Post-market clinical follow-up to confirm long-term safety and performance of the InterStim Micro System for sacral neuromodulation. The indications under investigation are overactive bladder, fecal incontinence, and non-obstructive urinary retention. Nonrandomized, open label study.
• EMBARK Pilot (Role: PI)
Funding: Investigator-initiated
Description: A pilot trial to study the effects of open label treatment of empagliflozin, a SGLT2i, on coronary and peripheral microvascular function in a small cohort of patients with non-obstructive coronary artery disease and coronary microvascular dysfunction diagnosed by coronary functional testing.
• MICRO-2 (Role: PI)
Funding: Industry Sponsor, Genetesis, Inc.
Description: A trial to validate CardioFlux MCG’s ability to diagnose myocardial ischemia caused by coronary microvascular dysfunction in patients with suspected INOCA by using diagnostic measures of coronary flow reserve (CFR) via invasive angiography as a reference standard for diagnosis. Prospective, multicenter, observational study.
• MICRO trial (Role: PI)
Funding: Genetesis
Description: Multi-center prospective observational study of ANOCA patients to investigate the ability and accuracy of magnetocardiography to detect coronary microvascular dysfunction as compared to reference-standard invasive coronary flow reserve.
• FREEDOM (Role: Co-I)
Funding: Industry Sponsor, Caladrius Biosciences
Description: Evaluation of the efficacy and safety of autologous CD34+ cells (CLBS16) in subjects with coronary microvascular dysfunction and without obstructive coronary artery disease.
• Liberate-H2H 003-011 (Role: PI)
Funding: Industry Sponsor, LIB Therapeutics, LLC.
Description: To evaluate the efficacy and safety of LIB003 compared to Evolocumab and Alirocumab in patients with or at high risk for cardiovascular disease, on stable lipid-lowering therapy requiring additional LDL reduction. LIB003 is an anti-PCSK9 small binding protein consisting of an Adnectin-fused human serum albumin in order to prevent its rapid renal clearance and enhance its half-life in circulation. Randomization is 2:2:1 to LIB003 or Repatha or Praluent every 4 weeks.
• Liberate-HR 003-006 (Role: Co-I)
Funding: Industry Sponsor, LIB Therapeutics, LLC.
Description: To evaluate the long-term efficacy and safety of LIB003 in patients with cardiovascular disease or at high risk for cardiovascular disease on stable lipid-lowering therapy requiring additional LDL reduction. LIB003 is an anti-PCSK9 small binding protein consisting of an Adnectin-fused human serum albumin in order to prevent its rapid renal clearance and enhance its half-life in circulation. Randomization is to LIB003 or placebo (2:1 respectively) every 4 weeks.
• Liberate-CVD 003-005 (Role: Co-I)
Funding: Industry Sponsor, LIB Therapeutics, LLC.
Description: To evaluate the long-term efficacy and safety of LIB003 in patients with cardiovascular disease on stable lipid-lowering therapy requiring additional LDL reduction. LIB003 is an anti-PCSK9 small binding protein consisting of an Adnectin-fused human serum albumin in order to prevent its rapid renal clearance and enhance its half-life in circulation. Randomization is to LIB003 or placebo (2:1 respectively) every 4 weeks.
• MyoKardia (Role: Co-PI)
Funding: Industry Sponsor, MyoKardia, Inc.
Description: Phase 2a proof of concept study to assess safety, tolerability, and preliminary efficacy of mavacamten treatment on cardiac troponin I (cTnI) levels and N-terminal pro-type natriuretic peptide (NT-proBNP) levels in participants with heart failure with preserved ejection fraction (HFpEF) and chronic elevation of cTnI and/or NT-proBNP.
1. Tzoumas A, Henry TD, Almanzar A, Kaur S, Cravero E, Ashokprabhu N, Rai S, Carnesi J, Hanycz C, Zhang J, Mahbub E, Lakhia E, Davis JT, Mohan A, Wilson K, Baker A, Forrest P, Hansen K, Hamstra M, Tapp D, Quesada O. ANOCA Patients With Prior Obstructive Coronary Artery Disease and PCI Have Higher Odds of Epicardial Spasm. JACC: Advances. 2026 Nov; 5(11):103319. doi:10.1016/j.jacadv.2026.203319.
2. Singh J, Dehghani P, Thakkar R, Ellingson CJ, Bainey KR, Mancini GBJ, Grines C, Mahmud E, Amlani S, Garberich R, Quesada O, Garcia S, Henry TD. Using pragmatic research methods to address a global pandemic: lessons learned from NACMI. COVID. 2026 Aug 1;6(8):138. doi: 10.3390/covid6080138.
3. Wong A, Muuse J, Iyengar A, Bhatia A, Quesada O, Henry TD. Complex MINOCA With Myocardial Bridge, Vasospasm, and Microvascular Dysfunction in an HCM Patient. JACC Case Rep. 2026 May 29:108613. doi: 10.1016/j.jaccas.2026.108613. Epub ahead of print. PMID: 42216946.
4. Tzoumas A, Tapp DN, Ashokprabu N, Schmidt CW, Kaur S, Carnesi J, Hanycz C, Lahkia E, Davis JT, Wilson K, Baker A, Almanzar A, Zhang J, Mahbub E, Rai S, Mohan A, Quesada O, Henry TD. Enhancing Invasive Coronary Function Testing: Multivessel Assessment of Coronary Microvascular Dysfunction in Patients with Angina and No Obstructive Coronary Artery Disease (ANOCA). Am Heart J. 2026 Mar 21:107429. doi: 10.1016/j.ahj.2026.107429. Epub ahead of print. PMID: 41871679.
5. Obrutu O, Gulati M, Reis S, Bittner V, Handberg E, Cook-Wiens G, Sedlak T, Quesada O, Pepine CJ, Bairey Merz CN, Wei J. Persistent chest pain trends at 3 years in women with INOCA vs. obstructive CAD: results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE). Eur Heart J Qual Care Clin Outcomes. 2026 Mar 5;12(2):250-258. doi: 10.1093/ehjqcco/qcaf133. PMID: 41288067. PMCID: PMC13017302.
6. Pabon M, Tapp D, Pico M, Vladutiu C, Schmidt C, DeFranco E, Kulandavelu S, Elfassy T, Minissian M, Bello N, Bairey Merz CN, Makarem N, Meyer M, Perreira K, Teng Y, Daviglus M, Kominiarek M, Rodríguez C, Hurwitz B, Talavera G, Cheng S, Quesada O. Preconception cardiometabolic markers and odds of developing adverse pregnancy outcomes: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) American Journal of Preventive Cardiology, 2026, 101494, ISSN 2666-6677
7. Shukla J, Schmidt C, Larson D, Murthy A, Chambers J, Garberich R, Smith L, Yildiz M, Quesada O, Mattingly G, Garcia S, Sharkey S, Henry TD. Clinical outcomes and discharge disposition in nonagenarians with ST-elevation myocardial infarction. Am Heart J. 2025 Dec;290:230-237. doi: 10.1016/j.ahj.2025.06.013. Epub 2025 Jun 27. PMID: 40582479; PMCID: PMC12426999.
8. Minissian MB, Kilpatrick S, Quesada O, Eastwood JA, Sharma KJ, Shufelt CL, Wei J, Doering LV, Spiro L, Luu M, Wiens GC, Merz CNB. Is spontaneous pre-term delivery associated with impaired arterial stiffness at 6 months postpartum? Am J Prev Cardiol. 2025 Sep 3;24:101286. doi: 10.1016/j.ajpc.2025.101286. PMID: 41030465; PMCID: PMC12478130.
9. Singulane CC, Wang S, Watts K, Stahl ME, Denlinger L, Lloyd R, Pallinti P, Preston L, Morsy M, Quesada O, Taylor A, Ramcharitar RK, Civelek M, Rodriguez-Lozano PF. Spontaneous Coronary Artery Dissection (SCAD): Unveiling the Enigma of the Unexpected Coronary Event. Curr Atheroscler Rep. 2025 Aug 15;27(1):81. doi: 10.1007/s11883-025-01328-5. PMID: 40815415; PMCID: PMC12356734.
10. Makarem N, Hosalli R, Lopez A, Dinh V, Caceres B, McClaim AC, Mullachery PH, Al-Rousan T, Quesada O. Status of cardiovascular health in United States immigrants using the American Heart Association’s Life’s Essential 8 framework: a population-based study prevalence estimates and determinants. Lancet Reg Health Am. 2025 May:46:101107. doi:10.1016/j.lana.2025.101107. eCollection 2025 Jun. PMID: 40485921. PMCID: PMC12141098.
11. Toleva O, Smilowitz NR, Quesada O, Kesarwani M, Savage MP, Prasad M, Barseghian El-Farra A, Holoshitz N, Moses JW, Fearon WF, Tremmel JA, Samuels B, Henry TD; Microvascular Network. Current Evidence-Based Treatment of Angina With Nonobstructive Coronary Arteries (ANOCA). J Soc Cardiovasc Angiogr Interv. 2025 Apr 15;4(7):102633. doi: 10.1016/j.jscai.2025.102633. PMID: 40933110; PMCID: PMC12418408.
12. Yildiz M, Pico M, Henry TD, Bergstedt S, Stanberry L, Chambers J, Shah A, Volpenhein L, Lantz R, Garberich RF, Aguirre FV, Garcia S, Sharkey SW, Quesada O. Sex Differences in Patients Presenting With ST-Segment Elevation Myocardial Infarction and Nonobstructive Coronary Arteries. Catheter Cardiovasc Interv. 2025 Apr;105(5):1204-1213. doi: 10.1002/ccd.31438. Epub 2025 Feb 5. PMID: 39906977.
13. Bullock-Palmer R, Gulati M, Lundberg G, Sanghavi M, Quesada O, Reza N, Grapsa J, Lee J, Volgman A, Mehta L, Lewis S, Tamirisa K. Cultivating a thriving environment for women in cardiology through leadership and inclusion American Heart Journal Plus: Cardiology Research and Practice, Volume 50, 2025, 100500, ISSN 2666-6022, https://doi.org/10.1016/j.ahjo.2025.100500.
14. Tapp D, Ashokprabhu N, Hamstra M, Losekamp M, Schmidt C, Palmer C, Gallatin J, Tierney D, Trenaman T, Canoniero M, Frizzell J, Henry T, Quesada O. Developing a Women’s Heart Center with a Specialization in Coronary Microvascular and Vasomotor Dysfunction (CMVD): If You Build It, They Will Come. Catheter Cardiovasc Interv. 2024 Dec;104(7):1337-1343. doi: 10.1002/ccd.31281. Epub 2024 Nov 6. PMID: 39506505.
15. Quesada O, Ashokprabhu N, Tapp D, Hamstra M, Losekamp M, Schmidt C, Palmer C, Gallatin J, Tierney D, Trenaman T, Canoniero M, Frizzell J, Henry T. Utilizing Invasive Coronary Functional Testing in a Coronary Microvascular and Vasomotor Dysfunction Program: Methods and Considerations. 2024. Catheter Cardiovasc Interv. 2024 Dec; 104(7):1327-1336. doi: 10.1002/ccd.31282. Epub 2024 Nov 17.
16. Tzoumas A, Quesada O, Henry TD. Invited Editorial. When is it a Bridge too far? JSCAI. 2024 Aug 12;3(9):102244, doi: 10.1016/j.jscai.2024.102244. eCollection 2024 Sep. PubMed PMID: 39575220; PubMed Central PMCID: PMC11576365.
17. Ebong IA, Quesada O, Fonkoue IT, Mattina D, Sullivan S, Oliveira GMM, Spikes T, Sharma J, Commodore Y, Ogunniyi MO, Aggarwal NR, Vaccarino V; American College of Cardiology Cardiovascular Disease in Women Committee. The Role of Psychosocial Stress on Cardiovascular Disease in Women: JACC State-of-the-Art Review. J Am Coll Cardiol. 2024 Jul 16;84(3):298-314. PMID: 38986672; PMCID: PMC11328148.
18. Ashokprabhu N, Ziada K, Schmidt CW, Daher E, Cho L, Palmer C, Henry TD, Pepine CJ, Quesada O. Evaluation of Coronary Microvascular Dysfunction Using Magnetocardiography: A New Application to an Old Technology. Am Heart J Plus. 2024 Jul 10;44:100424. PMID: 39108843; PMCID: PMC11301233.
19. Benson TW, Pike MM, Spuzzillo AR, Hicks SM, Pham M, Mix DS, Brunner S, Wadding-Lee CA, Conrad KA, Russell HM, Jennings CL, Coughlin TM, Aggarwal A, Lyden SP, Mani K, Bjorck M, Wanhainen A, Bhandari R, Lipworth L, Robinson-Cohen C, Caputo FJ, Shim S, Quesada O, Tourdot B, Edwards TL, Tranter M, Gardiner EE, Mackman N, Cameron SJ, Owens III AP. Soluble Glycoprotein VI Predicts Abdominal Aortic Aneurysm Growth Rate and is a Novel Therapeutic Target. Blood. 2024 Jun 20:blood.2023021655. PMID: 38900973.
20. Quesada O, Crousillat D, Rodriguez F, Bravo-Jaimes K, Briller J, Ogunniyi MO, Mattina DJ, Aggarwal NR, Rodriguez CJ, De Oliveira GMM, Velarde G. Cardiovascular Disease in Hispanic Women: JACC Review Topic of the Week. J Am Coll Cardiol. 2024 Apr 30;83(17):1702-1712 10.1016/j.jacc.2024.02.039. PMID: 38658109.
21. Lau ES, Aggarwal NR, Briller JE, Crousillat DR, Economy KE, Harrington CM, Lindley KJ, Malhamé I, Mattina DJ, Meng ML, Mohammed SF, Quesada O, Scott NS; ACC Cardiovascular Disease in Women Committee. Recommendations for the Management of High-Risk Cardiac Delivery: ACC Cardiovascular Disease in Women Committee Panel. JACC Adv. 2024 Mar 18;3(4):100901. doi: 10.1016/j.jacadv.2024.100901. PMID: 38939671; PMCID: PMC11198580.
22. Quesada O, Wu M, DeFranco E, Bello N, Wong M.S, Parbon, M, Minissian M, Chandra A, Makarem N, Aviles-Santa L, Rodriguez C, Vladutiu CJ, Talavera G, Henry D, Henry T, Bairey Merz CN, Sofer, T, Claggett, B, Solomon S, Cheng S. Cardiac Abnormalities in Hispanic/Latina Women with Prior De Novo Hypertensive Disorders of Pregnancy. Hypertension. 2024 Feb;81(2):255-263. PMID: 38047358; PMCID: PMC10793810.
23. Fox J, Ali F, Lopez M, Shah SA, Schmidt CW, Quesada O, Henry TD, Verduzco-Gutierrez M. Enhanced External Counterpulsation Improves Dyspnea, Fatigue, and Functional Capacity in Patients with Long COVID. COVID. 2024; 4(9):1379-1385.
24. Roca Alvarez Y, Pico M, Ashokprabhu N, Abou-Amro K, Bailey S, Pung E, Oberholster E, Quesada O. Polycystic Ovarian Syndrome a Risk Factor for Cardiovascular Disease. Curr Atheroscler Rep. 2023 Dec;25(12):1003-1011. PMID: 38048007.
25. Quesada O, Yildiz M, Henry TD, Bergstedt S, Chambers J, Shah A, Stanberry L, Volpenhein L, Aziz D, Lantz R, Palmer C, Ugwu L, Ahsan MJ, Garberich RF, Rohm HS, Aguirre FV, Garcia S, Sharkey SW. Mortality in STEMI with Non-Obstructive Coronary Arteries (MINOCA) and Mimickers. JAMA Network Open. 2023 Nov 1 ;6(11):e2343402. PMID: 36798420 PMCID: PMC9934717
26. Ashokprabhu ND, Fox J, Shah SA, Roca Alvarez Y, Schmidt CW, Tierney D, Thompson L, Henry TD, Quesada O. Enhanced External Counterpulsation for the Treatment of Angina with Nonobstructive Coronary Artery Disease (ANOCA). Am J Cardiol. 2023 Oct 27:S0002-9149(23)01213-4. PMID: 37890564; PMCID: PMC11188706.
27. Aziz D, Yildiz M, Quesada O, Henry TD. COVID-19 STEMI Related to Microthrombi May Lead to Coronary Microvascular Dysfunction. Catheter Cardiovasc Interv. 2023 Oct;102(4):641-645. Epub 2023 Aug 25. PMID: 37622612.
28. Samuels BA, Shah SM, Widmer RJ, Kobayashi Y, Miner SES, Taqueti VR, Jeremias A, Albadri A, Blair JA, Kearney KE, Wei J, Park K, Barseghian El-Farra A, Holoshitz N, Janaszek KB, Kesarwani M, Lerman A, Prasad M, Quesada O, Reynolds HR, Savage MP, Smilowitz NR, Sutton NR, Sweeny JM, Toleva O, Henry TD, Moses JW, Fearon WF, Tremmel JA; Microvascular Network (MVN). Comprehensive Management of ANOCA, Part 1-Definition, Patient Population, and Diagnosis: JACC State-of-the-Art Review. J Am Coll Cardiol. 2023 Sep 19;82(12):1245-1263. PMID: 37704315.
29. Smilowitz NR, Prasad M, Widmer RJ, Toleva O, Quesada O, Sutton NR, Lerman A, Reynolds HR, Kesarwani M, Savage MP, Sweeny JM, Janaszek KB, Barseghian El-Farra A, Holoshitz N, Park K, Albadri A, Blair JA, Jeremias A, Kearney KE, Kobayashi Y, Miner SES, Samuels BA, Shah SM, Taqueti VR, Wei J, Fearon WF, Moses JW, Henry TD, Tremmel JA; Microvascular Network (MVN). Comprehensive Management of ANOCA, Part 2-Program Development, Treatment, and Research Initiatives: JACC State-of-the-Art Review. J Am Coll Cardiol. 2023 Sep 19;82(12):1264-1279. PMID: 37704316.
30. Suppogu N, Tjoe B, Wei J, Maughan J, Joung S, Quesada O, Shufelt C, Samuels B, Azarbal B, Bairey Merz CN. Case Report: Repeat Coronary Function Testing in Women with Ischemia and No Obstructive Coronary Artery Disease. Front Cardiovasc Med. 2023 Jul 6;10:1096265. PMID: 37485267 PMCID: PMC10357037
31. Ashokprabhu ND, Quesada O, Alvarez YR, Henry TD. INOCA/MINOCA: Mechanisms and Novel Treatments. Am Heart J Plus. 2023 June;30:100302. PMID: 37377840 PMCID: PMC10299803
32. Ashokprabhu N, Roca Y, Quesada O. Invited Editorial: Female Sex and Acute Heart Failure Predict Mortality Following Acute Coronary Syndrome. JACC Adv. 2023 May 26;2(3):100353. PMID: 38939606; PMCID: PMC11198233.
33. Quesada O, Wei J, Suppogu N, Cook-Wiens G, Lauzon M, Reis S, Shaw L, Sopko G, Handberg E, Pepine C, C Bairey Merz N. Fitness attenuates long-term cardiovascular outcomes in women with ischemic heart disease and metabolic syndrome. Am J Prev Cardiol. 2023 April 23;14:100498. PMID: 37181803 PMCID: PMC10172715
34. Mehta PK, Levit RD, Wood MJ, Aggarwal N, O’Donoghue ML, Lim SS, Lindley K, Gaignard S, Quesada O, Vasta N, Leon A, Volgman AS, Malas W, Pepine CJ, on behalf of the American College of Cardiology Cardiovascular Disease in Women Committee. Chronic Rheumatologic Diseases and Cardiovascular Disease Risk in Women. Am Heart J Plus: Cardiology Research and Practice. March 2023;27(100267). PMID: 38511090; PMCID: PMC10945906.
35. Quesada O, Scantlebury D, Briller J, Michos ED, Aggarwal NR. Markers of Cardiovascular Risk Associated with Pregnancy. Curr Cardiol Rep. 2023 Feb;25(2):77-87. PMID: 36745273 PMCID: PMC10278153
36. Shah SM, Quesada O, Henry TD. The Challenge of Myocardial Bridging. J Soc Cardiovasc Angiogr Interv. 2023 January 3;1(100545).
37. Yildiz M, Ashokprabhu N, Shewale A, Pico M, Henry TD, Quesada O. Invited Review: Myocardial Infarction with Non -Obstructive Coronary Arteries (MINOCA). Front Cardiovasc Med. 2022 November 15;9:1032436. PMID: 36457805 PMCID: PMC9705379
38. Torosyan N, Aziz D, Quesada O. Long term sequelae of adverse pregnancy outcomes. Maturitas. 2022 Nov;165:1-7. PMID: 35816901
39. Ogunniyi MO, Hayes SE, Mahmoud Z, Commodore-Mensah Y, Fleg JL, Fatade Y, Quesada O, Aggarwal N, Mattina D, Oliveria GM, Lindley K, Ovbiagele B, Roswell RO, Douglass P, Itchhaporia D. Eliminating Disparities in Cardiovascular Disease for Black Women: From "Admiring the Problem" to Action. JACC Review Topic of the Week. 2022 Nov 1;80(18):1762-1771. PMID: 36302590 PMCID: PMC10278154
40. Henry TD, Quesada O, Wilson RF. Invited Editorial: Time Course of “Microvascular” Stunning in STEMI. Circ Cardiovasc Interv. 2022 Oct 28;15:e12528. PMID: 36305317 PMCID: PMC9988249
41. Zahid S, Harrington C, Michos E, Baker V, Quesada O, Shufelt C, Aggarwal N, Hashem A, Minhas A. Cardiovascular Complications During Delivery Admissions Associated with Assisted Reproductive Technology (From a National Inpatient Sample Analysis 2008-2019). Am J Cardiol. 2022 Oct 22;S0002-9149(22):00953-5. PMID: 36283885
42. Quesada O, Henry TD. Invited Article: Coronary Microvascular Disease in Patients with Obstructive Coronary Artery Disease. Cardiology. 2022 October 28. American College of Cardiology Magazine Spotlight Series.
43. Minissian M, Mehta P, Hayes S, Park K, Wei J, C Bairey Merz N, Cho L, Volgman A, Elgendy I, Mamas M, Davis M, Reynolds H, Epps K, Lindley K, Wood M, Quesada O, Piazza G, Pepine C. Ischemic Heart Disease in Young Women: JACC Review Topic of the Week. J Am Coll Cardiol. 2022 Sep;80(10):1014-1022. PMID: 36049799 PMCID: PMC9847245
44. Makarem M, Alcantara C, Musick S, Quesada O, Sears DD, Chen Z, Tehranifar P. Multidimensional Sleep Health is Associated with Cardiovascular Disease Prevalence and Cardiometabolic Health in a Nationally Representative Sample of US Adults. Int J Environ Res Public Health. 2022 Aug 29;19:10749. PMID: 36078471 PMCID: PMC9518578
45. Sarma AA, Aggarwal NR, Briller JE, Davis M, Economy KE, Elkayam U, Hameed A, Januzzi JL, Lindley KJ, Mattina DJ, McBay B, Quesada O, Scott NS on behalf of the American College of Cardiology Cardiovascular Disease in Women Committee and Cardio Obstetrics Committee. The Utilization and Interpretation of Cardiac Biomarkers During Pregnancy. JACC Adv. 2022 August;1(3):1-13.
46. Briller JE, Aggarwal NR, Davis MB, Hameed AB, Malhame I, Mahmoud Z, McDonald EG, Moraes de Oliveira G, Quesada O, Scott NS, Sharma J on behalf of the American College of Cardiology Cardiovascular Disease in Women Committee. Cardiovascular Complications of Pregnancy-Associated COVID-19 Infections. JACC Adv. 2022 August;1(3):1-11. PMID: 35967591 PMCID: PMC9364954
47. Lantz R, Quesada O, Mattingly G, Henry TD. Contemporary Management of Refractory Angina. Interv Cardiol Clin. 2022 Jul;11(3):279-292. PMID: 35710283 PMCID: PMC9275781
48. Quesada O, Van Hon L, Yildiz M, Madan M, Sanina C, Davidson L, Htun WW, Saw J, Garcia S, Deghani P, Stanberry L, Bortnick A, Henry TD, Grines C, Benziger C. Invited Manuscript. Sex Differences in Clinical Characteristics, Management Strategies, and Outcomes of STEMI with COVID-19: NACMI Registry. J Soc Cardiovasc Angiogr Interv. 2022 Jul-Aug;1(4):100360. PMID: 35812987 PMCID: PMC9117757
49. Quesada O, Wei J, Lauzon M, Suppogu N, Buttle R, Kelsey S, Reis S, Shaw L, Sopko G, Handberg E, Pepine C, C Bairey Merz N. Body weight and physical fitness in women with ischemic heart disease: Does physical fitness contribute to our understanding of the obesity paradox in women? Eur J Prev Cardiol. 2022 Mar 4;zwac046. PMID: 35244151 PMCID: PMC9440958
50. Sharma J, McAlister J, Aggarwal NR, Wei J, Mehta PK, Quesada O, Mattina D, Scott NS, Mahmoud Z, Kurrelmeyer K, Moraes De Oliveira GM, Lindley KJ. Evaluation and Management of Blood Lipids Through a Woman’s Life Cycle. Am J Prev Cardiol. 2022 March 13;10:100333. PMID: 35345879 PMCID: PMC8956895
51. Quesada O, Elboudwarej O, Nelson M, Al-Badri A, Mastali M, Wei J, Zarrabi B, Suppogu N, Aldiwani H, Mehta P, Shufelt C, Cook-Wiens G, Berman D, Thomson L, Handberg E, Pepine C, Van Eyk J, C Bairey Merz N. Ultra-high Sensitivity Cardiac Troponin-I Concentration and Left Ventricular Structure and Function in Women with Ischemia and No Obstructive Coronary Artery Disease. Am Heart J Plus: Cardiology Research and Practice. 2022 March 3;13:100115. PMID: 35784010 PMCID: PMC9246284
52. Aldiwani H, Nelson DM, Sharif B, Wei J, Samuel T. J, Suppogu N, Quesada O, Cook-Wiens G, Gill E, Szczepaniak S. L, Thomson EJT, Tamarappoo B, Asif A, Shufelt C, Berman D, Bairey Merz CN. Reduced Myocardial Perfusion Is Common Among Subjects with Ischemia and No Obstructive Coronary Artery Disease and Heart Failure with Preserved Ejection Fraction: A Report from the WISE-CVD Continuation Study. Vessel Plus. 2022;6:16. Epub 2022 March 5. PMID: 35836794 PMCID: PMC9278056
53. O’Kelly CA, Michos ED, Shufelt CL, Vermunt JV, Minissian MB., Quesada O., Smith G, Rich-Edwards JW, Garovic VD, El Khoudary SR, Honigberg MC. Pregnancy and Reproductive Risk Factors for Cardiovascular Disease in Women. Circ Res. 2022 Feb 18;130(4):652–672. PMID: 35175837. PMCID: PMC8870397
54. Henry Y, C Bairey Merz N, Wei J, Corban M, Quesada O, Joung S, Kotynski C, Wang J, Lewis M, Schumacher A, Bartel R, Takagi H, Shah V, Sietsema W, Losordo D, Lerman A. Autologous CD34+ stem cell therapy increases coronary flow reserve and reduces angina in patients with coronary microvascular dysfunction. Circ Cardiovasc Interv. 2022 Feb;15(2):e010802. PMID: 35067072 PMCID: PMC8843403
55. Mehta P, Quesada O, Al-Badri A, Fleg J, Volgman AS, Pepine C, Bairey Merz CN, Shaw LJ. Ischemia and No Obstructive Coronary Arteries in Patients with Stable Ischemic Heart Disease. Int J Cardiol. 2021 Dec 11;S0167-5273(21)02005-2. PMID: 34902504 PMCID: PMC8779638
56. Lindley JK, Aggarwal RN, Briller EJ, Davis BM, Douglass P, Epps CK, Fleg LJ, Hayes S, Itchhaporia D, Mahmoud Z, Moraes De Oliveira G, Ogunniyi OM, Quesada O, Russo MA, Sharma J, Wood JM. Socioeconomic Determinants of Health and their Relationship to Cardiovascular Outcomes in Women: JACC Review Topic of the Week. J Am Coll Cardiol. 2021 Nov 9;78(19):1919-1929. PMID: 34736568
57. Mehta PK, Wei J, Shufelt C, Quesada O, Shaw L, Bairey Merz CN. Gender-Related Differences in Chest Pain Syndromes in the Frontiers in CV Medicine Special Issue: Sex and Gender in CV Medicine. Front Cardiovasc Med. 2021 November 17;8:744788. PMID: 34869650 PMCID: PMC8635525
58. Quesada O, Henry TD. Functional coronary angiography for coronary microvascular function: the time has come! Catheter Cardiovasc Interv. 2021 Nov 1;98(5):836-837. PMID: 34752008 PMCID: PMC9246295
59. Quesada O, Claggett B, Rodriguez F, Cai J, Moncrieft AE, Garcia K, Del Rios Rivera M, Hanna DB, Daviglus ML, Talavera GA, Bairey Merz CN, Solomon SD, Cheng S, Bello NA. Associations of Insulin Resistance With Systolic and Diastolic Blood Pressure: A Study From the HCHS/SOL. Hypertension. 2021 Sep;78(3):716-725. PMID: 34379440 PMCID: PMC8650976
60. Mehta PK, Thomson LEJ, Slomka PJ, Hayes SW, Friedman JD, Swift A, Quesada O, Wei J, Shaw LJ, Nelson MD, Li L, Hermel D, Hermel MH, Irwin MR, Krantz DS, Travin MI, Pepine CJ, Berman DS, Bairey Merz CN. Cardiac Sympathetic Activity by I-Meta-Iodobenzylguanidine Imaging in Women With Coronary Microvascular Dysfunction: A Pilot Study. JACC Cardiovasc Imaging. 2021 Sep;14(9):1873-1875. PMID: 34147436 PMCID: PMC9186182
61. Rai B, Shukla J, Henry TD, Quesada O. Angiogenic CD34 Stem Cell Therapy in Coronary Microvascular Repair-A Systematic Review. Cells. 2021 May 8;10(5):1137. PMID: 34066713 PMCID: PMC8151216
62. Quesada O, Shandhi MMH, Beach S, Dowling S, Tandon D, Heller J, Etemadi M, Roy S, Gonzalez Velez JM. Use of Ballistocardiography to Monitor Cardiovascular Hemodynamics in Preeclampsia. Womens Health Rep (New Rochelle). 2021 Apr 20;2(1):97-105. PMID: 33937907 PMCID: PMC8080913
63. Bello NA, Bairey Merz CN, Brown H, Davis MB, Dickert NW, El Hajj SC, Giullian C, Quesada O, Park K, Sanghani RM, Shaw L, Volgman AS, Wenger NK, Williams D, Pepine DJ, Lindley KJ; American College of Cardiology Cardiovascular Disease in Women Committee and the Cardio-Obstetrics Work Group. Diagnostic Cardiovascular Imaging and Therapeutic Strategies in Pregnancy: JACC Focus Seminar 4/5. J Am Coll Cardiol. 2021 Apr 13;77(14):1813-1822. PMID: 33832607 PMCID: PMC8221542
64. Quesada O, Henry TD. New Generation Drug Eluting Stents: Closing the Gap in Sex Disparity in Cardiovascular Outcomes in Women. Catheter Cardiovasc Interv. 2021 Apr 1;97(5):805-806. PMID: 33851789 PMCID: PMC8252807
65. Suppogu N, Wei J, Quesada O, Shufelt C, Cook-Wiens G, Samuels B, Petersen JW, Anderson D, Handberg EM, Pepine CJ, Bairey Merz CN. Angina Relates to Coronary Flow in Women with Ischemia and No Obstructive Coronary Artery Disease. Int J Cardiol. 2021 Mar 1;S0167-5273(21)00373-9. PMID: 33662486 PMCID: PMC8107128
66. Volgman AS, Benjamin EJ, Curtis AB, Fang MC, Lindley KJ, Naccarelli GV, Pepine CJ, Quesada O, Vaseghi M, Waldo AL, Wenger NK, Russo AM; American College of Cardiology Committee on Cardiovascular Disease in Women. Women and Atrial Fibrillation. J Cardiovasc Electrophysiol. 2020 Dec 17. PMID: 33332669 PMCID: PMC8281363
67. AlBadri A, Wei J, Quesada O, Mehta PK, Xiao Y, Ko Y, Anderson RD, Petersen J, Azarbal B, Samuels B, Henry TD, Cook-Wiens G, Handberg EM, Van Eyk J, Pepine CJ, Bairey Merz CN. Coronary Vascular Function and Cardiomyocyte Injury: A Report WISE-CVD. Arterioscler Thromb Vasc Biol. 2020. Dec;40(12):3015-3021. PMID: 33028098 PMCID: PMC8079158
68. Quesada O, Henry TD. STEMI in young women: Don’t miss spontaneous coronary artery dissection! Catheter Cardiovasc Interv. 2020 Nov;96(6):1231.1232. PMID: 33217189 PMCID: PMC8284602
69. Quesada O, Shufelt C, Bairey Merz CN. Can We Improve Cardiovascular Disease for Women Using Data Under Our Noses? A Need for Changes in Policy and Focus. JAMA Cardiol. 2020 Sep 16. PMID: 32936208 PMCID: PMC8074640
70. Quesada O, Park K, Wei J, Handberg E, Shufelt C, Minissian M, Cook-Wiens G, Zarrini P, Pacheco C, Tamarappoo B, Thomson LEJ, Berman DS, Pepine CJ, Bairey Merz N. Left Ventricular Mass and Myocardial Scarring in Women with Hypertensive Disorders of Pregnancy. Open Heart 2020 Aug;7(2):e001273. PMID: 32763966 PMCID: PMC7412584
71. Quesada O, Hermel M, Suppogu N, Aldiwani H, Shufelt C, Mehta PK, Cook-Wiens G, Maughan J, Berman DS, Thomson LEJ, Handberg EM, Pepine CJ, Bairey Merz CN, Wei J. Temporal Trends in Angina, Myocardial Perfusion, and Left Ventricular Remodeling in Women with No Obstructive Coronary Artery Disease Over 1-Year Follow up: Results From (WISE-CVD) the Women's Ischemia Syndrome Evaluation Coronary Vascular Dysfunction Study. J Am Heart Assoc. 2020 Jul 7;9(13):e016305. PMID: 32578481 PMCID: PMC7670509
